Prosecution Insights
Prosecution Insights
13 pending office actions • 12 clients • 13 examiners • 9 art units • 0 of 13 (0%) have an AI response strategy ready • 24 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 13 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 13 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 7 (54%) |
| §112 only | 2 (15%) |
| Double-patenting + other | 1 (8%) |
| No statute on record | 3 (23%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VERA, ELISA H | 1 | 71.6% | +26.7% |
| SHOMER, ISAAC | 1 | 63.1% | +30.7% |
| RODRIGUEZ-GARCIA, VALERIE | 1 | 68.7% | +31.6% |
| SEITZ, ANTHONY JOSEPH | 1 | 68.8% | +28.3% |
| JOHNSON, TIRONE DEREK | 1 | — | — |
| LEE, YIE CHIA | 1 | 72.7% | +43.4% |
| BORGEEST, CHRISTINA M | 1 | 55.4% | +22.1% |
| MARTIN, KEVIN STEPHEN | 1 | 75.9% | +23.6% |
| AEDER, SEAN E | 1 | 56.9% | +19.6% |
| MCDOWELL, BRIAN E | 1 | 74.3% | +30.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18346961 | ANTI-CGRP COMPOSITIONS AND USE THEREOF | BORGEEST, CHRISTINA M | 60d overdue |
| 18392143 | COMPOSITIONS AND SYSTEMS COMPRISING TRANSFECTION-COMPETENT VESICLES FREE OF ORGANIC-SOLVENTS AND DETERGENTS AND METHODS RELATED THERETO | SHOMER, ISAAC | 25d overdue |
| 18278639 | CO-EXPRESSED CXCR2 AND T CELLS OF STAR SPECIFIC TO GPC3, AND USE THEREOF | LEE, YIE CHIA | 22d overdue |
| 18837911 | HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYSACCHARIDE PROMOTER | VERA, ELISA H | 10d overdue |
| 18023405 | PREPARATION METHOD FOR NOVEL RHO-RELATED PROTEIN KINASE INHIBITOR AND INTERMEDIATE IN PREPARATION METHOD | MCDOWELL, BRIAN E | 6d |
| 18029400 | EGFR-TARGETING CHIMERIC ANTIGEN RECEPTOR | AEDER, SEAN E | 22d |
| 18269783 | PHARMACEUTICAL COMPOSITION CONTAINING PYRROLOQUINOLINE QUINONE TRILITHIUM SALT NONAHYDRATE COMPOUND, CAPSULE, AND PREPARATION METHOD THEREFOR | MARTIN, KEVIN STEPHEN | 26d |
| 18283465 | THIOPHENE GLP-1 RECEPTOR AGONIST AND USE THEREOF | SEITZ, ANTHONY JOSEPH | 34d |
| Art Unit | Apps |
|---|---|
| 1675 | 3 |
| 1642 | 2 |
| 1624 | 2 |
| 1748 | 1 |
| 1612 | 1 |
| 1621 | 1 |
| 1629 | 1 |
| 1622 | 1 |
| 1643 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18837911 | HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYSACCHARIDE PROMOTER | Kemira Oyj | VERA, ELISA H | 1748 | §103 | Non-Final OA | 10d overdue | Pending | Aug 13, 2024 |
| 18392143 | COMPOSITIONS AND SYSTEMS COMPRISING TRANSFECTION-COMPETENT VESICLES FREE OF ORGANIC-SOLVENTS AND DETERGENTS AND METHODS RELATED THERETO | The University of British Columbia | SHOMER, ISAAC | 1612 | Other | Non-Final OA | 25d overdue | Pending | Dec 21, 2023 |
| 18283834 | NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOF | Jacobio Pharmaceuticals Co., Ltd. | RODRIGUEZ-GARCIA, VALERIE | 1621 | §112 | Non-Final OA | 60d | Pending | Sep 25, 2023 |
| 18283465 | THIOPHENE GLP-1 RECEPTOR AGONIST AND USE THEREOF | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | SEITZ, ANTHONY JOSEPH | 1629 | §103 | Final Rejection | 34d | Pending | Sep 22, 2023 |
| 18283385 | MULTISPECIFIC PROTEINS COMPRISING AN NKP46-BINDING SITE, A CANCER ANTGIENGE BINDING SITE FUSED TO A CYTOKINE FOR NK CELL ENGAGING | Innate Pharma | JOHNSON, TIRONE DEREK | 1675 | §103 | Non-Final OA | 34d | Pending | Sep 21, 2023 |
| 18278639 | CO-EXPRESSED CXCR2 AND T CELLS OF STAR SPECIFIC TO GPC3, AND USE THEREOF | (Shanghai Icell Biotechnology Co., Ltd.) | LEE, YIE CHIA | 1642 | §103 | Non-Final OA | 22d overdue | Pending | Sep 06, 2023 |
| 18346961 | ANTI-CGRP COMPOSITIONS AND USE THEREOF | Alderbio Holdings LLC | BORGEEST, CHRISTINA M | 1675 | Other | Final Rejection | 60d overdue | Pending | Jul 05, 2023 |
| 18269783 | PHARMACEUTICAL COMPOSITION CONTAINING PYRROLOQUINOLINE QUINONE TRILITHIUM SALT NONAHYDRATE COMPOUND, CAPSULE, AND PREPARATION METHOD THEREFOR | Shanghai Raising Pharmaceutical Co., Ltd. | MARTIN, KEVIN STEPHEN | 1624 | Other | Non-Final OA | 26d | Pending | Jun 27, 2023 |
| 18029400 | EGFR-TARGETING CHIMERIC ANTIGEN RECEPTOR | BEIJING INSTITUTE FOR STEM CELL AND REGENERATIVE MEDICINE | AEDER, SEAN E | 1642 | §103 | Non-Final OA | 22d | Pending | May 04, 2023 |
| 18023405 | PREPARATION METHOD FOR NOVEL RHO-RELATED PROTEIN KINASE INHIBITOR AND INTERMEDIATE IN PREPARATION METHOD | BEIJING TIDE PHARMACEUTICAL CO., LTD. | MCDOWELL, BRIAN E | 1624 | §112 | Non-Final OA | 6d | Pending | Feb 27, 2023 |
| 18015096 | PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | Shanghai Raising Pharmaceutical Co., Ltd. | JAVANMARD, SAHAR | 1622 | §103 | Final Rejection | 34d | Pending | Jan 09, 2023 |
| 18148448 | WNT RECEPTOR-SPECIFIC COMPOUND AND METHOD RELATING THERETO | Surrozen Operating, Inc. | WANG, CHANG YU | 1675 | DPOther | Non-Final OA | 77d | Pending | Dec 30, 2022 |
| 18008278 | Improved T cell receptor-costimulatory molecule chimera | Tsinghua University | CHATTIN, AMY MARIE | 1643 | §103 | Non-Final OA | 26d overdue | Pending | Dec 05, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial